GSK Investigational Site

Hattingen, North Rhine-Westphalia 45525

0 studies enrolling now · 6 studies all time

What they study most

Alzheimer's Disease, Arthritis, Rheumatoid, Epilepsy, Epilepsy, Partial, Epilepsy, Tonic-Clonic, Neuralgia, Postherpetic

Studies at this site

• Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease — Completed
• Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate Alzheimers — Stopped early
• COX-2 Inhibitor Study In Patients With Rheumatoid Arthritis — Completed
• Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Primary Generalized Tonic-Clonic Seizures (PGTC) Seizures — Completed
• Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures — Completed
• A Clinical Study in Subjects With Neuropathic Pain From PHN Who Have Had an Inadequate Response to Gabapentin Treatment — Completed